Can tapering off Weight-Loss drugs prevent regain? new study investigates
NCT ID NCT07294950
First seen Jan 05, 2026 · Last updated May 22, 2026 · Updated 23 times
Summary
This study looks at what happens when people stop taking the weight-loss drug semaglutide. It compares two strategies: stopping all at once versus slowly reducing the dose. The goal is to see which approach helps maintain weight loss and heart health. About 98 adults who have already lost at least 10% of their body weight on semaglutide will participate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY (DISORDER) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Leadership Sinai Centre for Diabetes
RECRUITINGToronto, Ontario, M5T 3L9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.